Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RVT-101 in dementia with Lewy bodies
2015-005495-19Phase 2Completed
- Sponsor
- Sio Gene Therapies
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dementia with Lewy bodies (DLB) comparing RVT-101 with Placebo (2 arms). Primary endpoints: Change from baseline to Week 24 in cognition and Global function at Week 24. Started Apr 2016; status: completed.
02
Drugs
intepirdine
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on 2015-005495-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005495-19.